Product image of Kidiamix G (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine) supplied by GNH India

Kidiamix G

Active Ingredient:
Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine
Origin:
EU

Kidiamix G (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Amino acid solution, the active ingredient in Kidiamix G, is an amino acid solution presented as a solution for injection for parenteral use. It provides a balanced mixture of essential and non‑essential amino acids to support protein synthesis and maintain nitrogen balance in patients receiving parenteral nutrition, particularly those who cannot meet their protein requirements orally or enterally.

GNH India supplies Kidiamix G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Manufacturer / TM Owner

Fresenius Kabi Nv/Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Kidiamix G, an amino acid solution used in parenteral nutrition, addresses protein and nitrogen requirements in several clinical situations.
  • Parenteral nutrition: provides a complete amino acid profile to meet protein and nitrogen needs when oral or enteral intake is insufficient.
  • Critical illness: supports ongoing protein synthesis and helps preserve lean body mass in critically ill patients receiving intensive care.
  • Post‑operative care: supplies essential amino acids to promote wound healing and recovery after major surgery.
  • Severe trauma: aids metabolic recovery by delivering necessary amino acids during catabolic stress.

How It Works

  • Kidiamix G delivers a mixture of essential and non‑essential amino acids directly into the bloodstream. These amino acids are taken up by cells and incorporated into newly formed proteins, supporting protein synthesis, tissue repair, and maintenance of nitrogen balance. By bypassing the gastrointestinal tract, the solution ensures rapid availability of substrates for metabolic processes in patients who cannot absorb nutrients orally or enterally.

Side Effects

Common adverse reactions associated with Kidiamix G infusion include:

Common Side Effects

  • Phlebitis at infusion site: mild inflammation of the vein.
  • Hypernatremia: elevated serum sodium levels.
  • Metabolic alkalosis: shift toward higher blood pH.
  • Hyperglycemia: increased blood glucose in susceptible patients.

Serious or rare reactions that require immediate medical attention may include:

Serious or Rare Side Effects

  • Anaphylactic reaction: severe hypersensitivity with respiratory compromise.
  • Electrolyte disturbances: severe hyperkalemia or hypocalcemia.
  • Hepatic dysfunction: marked elevation of liver enzymes.
  • Renal impairment: worsening kidney function or oliguria.

Precautions & Warnings

Kidiamix G should be used with careful clinical monitoring.

  • Assess renal function: adjust infusion rate in patients with renal impairment.
  • Monitor electrolytes: check serum electrolytes regularly during therapy.
  • Evaluate hepatic status: watch for changes in liver enzyme levels.
  • Use aseptic technique: prevent contamination during preparation and administration.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Kidiamix G may interact with other medications or solutions.

Major Interactions (Avoid)

  • Concurrent high‑dose potassium supplements: risk of hyperkalemia.
  • Acidifying agents (e.g., ammonium chloride): may destabilize the amino acid solution.

Moderate Interactions (Monitor Closely)

  • Diuretics: may alter electrolyte balance and require monitoring.
  • Insulin therapy: monitor blood glucose as amino acids can affect glucose metabolism.
  • Other parenteral nutrition components: adjust total nutrient composition to avoid excesses.

Frequently Asked Questions

Kidiamix G is an amino acid solution intended for parenteral nutrition. It supplies essential and non‑essential amino acids to patients who cannot meet their protein needs through oral or enteral feeding, such as those in intensive care, postoperative recovery, or severe trauma.

The solution provides a balanced mixture of amino acids that are directly infused into the bloodstream. Cells absorb these amino acids and incorporate them into proteins, supporting tissue repair, maintaining nitrogen balance, and facilitating metabolic processes that are critical during illness or after surgery.

The dose of Kidiamix G is individualized. A qualified prescriber determines the amount and infusion rate based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional requirements.

Safety data for Kidiamix G in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Kidiamix G, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Kidiamix G offers a comprehensive profile of essential and non‑essential amino acids similar to other parenteral amino acid formulations such as Clinimix or Aminosyn. Differences may lie in individual amino‑acid concentrations, osmolarity, and excipients, which can affect tolerability and compatibility with other intravenous therapies.

Kidiamix G must be stored at 2‑8 °C in a refrigerator, protected from light. Do not freeze or shake the container. Before use, inspect the solution for particulate matter or discoloration and follow aseptic techniques during preparation.

Kidiamix G is administered intravenously as an infusion. It should be prepared under sterile conditions, diluted if required by the prescribing protocol, and infused over the time period recommended by the clinician, typically using an infusion pump to control the rate.

Serious risks include anaphylactic reactions, severe electrolyte disturbances such as hyperkalemia or hypocalcemia, hepatic dysfunction indicated by marked enzyme elevations, and renal impairment that may worsen existing kidney disease. Immediate medical attention is required if any of these occur.

Kidiamix G should be avoided in patients with known hypersensitivity to any of its amino‑acid components, in those with uncontrolled severe renal or hepatic failure, and in individuals where the risk of fluid overload outweighs the nutritional benefit. Clinical judgment is essential.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.